- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Dermatitis herpetiformis Leprosy Actinomycotic mycetoma
- Meeting Date: March 2025
- Public Summary Document (PSD) March 2025 PBAC Meeting - (PDF)
- Public Summary Document (PSD) March 2025 PBAC Meeting - (Word)
Dapsone – March 2025
Dapsone; Tablet 50 mg; Dapsomed®
Last updated
12 March 2025